Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-168 manufacturers

Filters

Filters

Filters , active

Country of origin : Israel
1 products found

pp-168

Capsules

Dossier type
CTD
Dossier status
Under development
Country of origin
Israel
GMP approvals
Israel
Comments
Indication: Acute radiation syndrome (ARS — hematopoietic and gastrointestinal); oncology (NSCLC, cholangiocarcinoma) Clinical stage: Phase 2/3 (ARS — BARDA-funded); Phase 2 oncology Modality: Small molecule Mechanism / Target: Selective sphingosine kinase-2 (SphK2) inhibitor — reduces sphingosine-1-phosphate (S1P) production; promotes ceramide-mediated apoptosis in tumour cells and radioprotection in normal tissue Route / form: Oral capsule (500 mg twice daily) Differentiation: Dual oncology/radioprotection utility; BARDA support for ARS indication; selective SphK2 (vs SphK1) targets S1P pathway differently from prior approaches; oral administration
Manufacturer #39192

Specialty pharmaceutical company developing treatments for gastrointestinal and infectious diseases. Advances novel combination regimens for hard-to-treat bacterial infections and GI conditions. Wholly owned pipeline with Phase 3 assets in NTM lung disease.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.